Evoq Remedies (BOM:543500) Retained Earnings : ₹31.96 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Evoq Remedies Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Evoq Remedies's retained earnings for the quarter that ended in Mar. 2024 was ₹31.96 Mil.

Evoq Remedies's quarterly retained earnings declined from Mar. 2023 (₹27.44 Mil) to Sep. 2023 (₹0.00 Mil) but then increased from Sep. 2023 (₹0.00 Mil) to Mar. 2024 (₹31.96 Mil).

Evoq Remedies's annual retained earnings increased from Mar. 2022 (₹11.24 Mil) to Mar. 2023 (₹27.44 Mil) and increased from Mar. 2023 (₹27.44 Mil) to Mar. 2024 (₹31.96 Mil).

Evoq Remedies Retained Earnings Historical Data

The historical data trend for Evoq Remedies's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evoq Remedies Retained Earnings Chart

Evoq Remedies Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Retained Earnings

Get a 7-Day Free Trial

7.33

11.24

27.44

31.96

Evoq Remedies Semi-Annual Data
	Mar19	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Retained Earnings	Get a 7-Day Free Trial				11.24	-	27.44	-	31.96

Evoq Remedies Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Evoq Remedies (BOM:543500) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Evoq Remedies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Evoq Remedies Ltd (BOM:543500) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

Science City Road, A-1106, Empire Business Hub, Near AUDA Water Tank, Sola, Ahmedabad, GJ, IND, 380060

Website

http://www.evoqremedies.com

Evoq Remedies Ltd is engaged in the pharmaceutical business involving marketing, trading, and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, calcium, multivitamins, injections, and others. It operates in a single segment that is Pharmaceutical Trading.

Evoq Remedies Headlines

No Headlines